EEP logo

Euroespes, S.A. Stock Price

BME:EEP Community·€3.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

EEP Share Price Performance

€0
0.00 (0.00%)
€0
0.00 (0.00%)
Price €0

EEP Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slightly overvalued with worrying balance sheet.

4 Risks
1 Reward

Euroespes, S.A. Key Details

€3.9m

Revenue

€2.5m

Cost of Revenue

€1.4m

Gross Profit

€2.5m

Other Expenses

-€1.1m

Earnings

Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
n/a
-0.11
35.92%
-29.49%
68.3%
View Full Analysis

About EEP

Founded
1991
Employees
39
CEO
Ramon Cacabelos Garcia
WebsiteView website
www.euroespes.com

Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, digital diagnostics, radiodiagnosis, clinical analysis laboratory, nursing, and cardiology. In addition, it researches and develops in the fields of biochemistry, health biotechnology, epigenetics, pharmacogenomics, and nutraceuticals. The company was founded in 1991 and is based in Corunna, Spain.

Recent EEP News & Updates

Recent updates

No updates

Euroespes, S.A. Competitors